The ability of mutations to cause cancer depends on how fast they force cells to divide, Sinai Health researchers have found. The study, led by Dr. Rod Bremner, a Senior Investigator at the ...
The review emphasizes how breakthroughs in understanding the molecular mechanisms of cell cycle regulation have paved the way for the development of targeted anti-cancer agents. Notably, inhibitors of ...
News-Medical.Net on MSN
Study identifies a powerful strategy to overcome drug resistance in breast cancer
A new preclinical study from researchers at The University of Texas MD Anderson Cancer Center, published today in Nature ...
FAYETTEVILLE, GA, UNITED STATES, January 15, 2026 /EINPresswire.com/ -- Understanding why cancer cells rely on specific ...
16h
Study by Indian researchers finds that body’s immune cells ‘betray’ it to help breast cancer spread
Indian researchers reveal how immune cells 'betray' the body, aiding breast cancer spread and suggesting new treatment ...
SurvivorNet on MSN
Could timing give your cancer treatment a boost? New study on the best time to receive immunotherapy & chemo for non-small cell lung cancer
A new randomized clinical trial showed that receiving immunochemotherapy infusions earlier in the day may help patients with ...
A new study shows that cancer damages its own DNA by pushing key genes to work too hard. Researchers found that the most ...
SurvivorNet on MSN
More control, better quality of life: What to know about tarlatamab, the new immunotherapy drug approved for small-cell lung cancer
Tarlatamab (Imdelltra) is a new type of immunotherapy approved for people with small-cell lung cancer whose disease has progressed after chemotherapy and immunotherapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results